- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07767734
Comparison of the BOPPPS Model and Traditional Instructional Method in Medicinal Chemistry Education
2026년 8월 11일 업데이트: Liang Qi, Jiangsu Medical College
Comparison of the BOPPPS Model and Traditional Instructional Method in Medicinal Chemistry Education for Pharmacy Students
This study aims to compare the teaching effect of the BOPPPS teaching model and the traditional lecture-based teaching method in Medicinal Chemistry courses for pharmacy students.
Two groups of students receiving different teaching strategies will be included in this retrospective controlled study.
The primary evaluation indicators include students' final examination scores, and secondary indicators cover classroom learning engagement and student satisfaction questionnaires.
The overall objective is to explore whether the BOPPPS model can improve students' learning performance and learning experience in Medicinal Chemistry teaching.
No human clinical intervention or invasive testing is involved in this educational research.
연구 개요
상태
완전한
상세 설명
This educational controlled study focuses on the teaching reform of Medicinal Chemistry, a core compulsory course for pharmacy majors in higher vocational colleges.
Traditional lecture-centered teaching is widely adopted in vocational pharmacy teaching, which often leads to insufficient student participation, weak initiative in classroom interaction, and unsatisfactory learning efficiency for complex pharmaceutical chemical structures and synthetic reactions.The BOPPPS teaching model divides each class into six standardized links: Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment, Summary.
This student-centered teaching design strengthens classroom interaction and targeted detection of learning effects.
At present, there is limited comparative research on the application of this model in Medicinal Chemistry teaching for vocational pharmacy students.This retrospective controlled research collects historical teaching data of two student groups receiving different teaching modes.
The research intends to systematically analyze the differences in learning outcomes between the two teaching strategies, so as to provide practical teaching reform references for Medicinal Chemistry courses in vocational pharmacy education.
This study only adopts routine classroom teaching and anonymous questionnaire surveys, without any clinical medical intervention, blood sampling or physical examination on participants.
All student data are anonymized to protect personal privacy.
Article 32 of the Notice on Printing and Distributing the Measures for Ethical Review of Life Science and Medical Research Involving Humans, jointly issued by the National Health Commission of China, the Ministry of Education, the Ministry of Science and Technology, and the National Administration of Traditional Chinese Medicine, stipulates that "Life science and medical research involving humans that uses human information, data or biological samples may be exempt from ethical review if such research falls under the circumstances specified below, causes no physical harm to human participants, and does not involve sensitive personal information or commercial interests."
As a study focusing on teaching effectiveness, the present research qualifies for an exemption from ethical review pursuant to this provision.
연구 유형
중재적
등록 (실제)
60
단계
- 해당 없음
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 장소
-
-
Jiangsu
-
Yancheng, Jiangsu, 중국, 224005
- Jiangsu Medical College
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
- 어린이
- 성인
건강한 자원 봉사자를 받아들입니다
예
설명
Inclusion Criteria:
- Full-time pharmacy students without previous Medicinal Chemistry learning experience
- Complete all academic assessments and anonymous questionnaire surveys
Exclusion Criteria:
- Classroom attendance rate less than 80%
- Students who are unwilling to provide relevant data for this educational study or miss the final exam
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 다른
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Experimental Group (BOPPPS Teaching Model)
Pharmacy students receive Medicinal Chemistry courses adopting the complete six-link BOPPPS teaching design, including Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment and Summary.
Interactive classroom activities and in-class tests are arranged in each lesson.
|
Medicinal Chemistry teaching based on BOPPPS model, consisting of Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment and Summary sessions with abundant classroom interaction.
|
|
활성 비교기: Control Group (Traditional Lecture Teaching)
Pharmacy students receive teacher-centered traditional lecture-based Medicinal Chemistry teaching.
The teacher explains knowledge points directly, with few classroom interactive sessions.
|
Traditional teacher-centered lecture teaching for Medicinal Chemistry, mainly knowledge explanation, without segmented pre-assessment and post-assessment arrangements.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Final examination scores of Medicinal Chemistry
기간: At the completion of the teaching intervention, up to 1 week
|
Final exam scores to evaluate students' mastery of professional knowledge of Medicinal Chemistry.
Scores range from 0 to 100.
Higher scores indicate better academic performance.
|
At the completion of the teaching intervention, up to 1 week
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Student teaching satisfaction score
기간: At the completion of the teaching intervention, up to 1 week
|
Score from an anonymous questionnaire evaluating students' satisfaction with the classroom teaching model.
The total score ranges from 1 to 5. Higher scores indicate higher satisfaction.
|
At the completion of the teaching intervention, up to 1 week
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
수사관
- 수석 연구원: Liang Qi, PhD, Jiangsu Medical College
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (실제)
2025년 9월 15일
기본 완료 (실제)
2026년 1월 6일
연구 완료 (실제)
2026년 1월 8일
연구 등록 날짜
최초 제출
2026년 8월 6일
QC 기준을 충족하는 최초 제출
2026년 8월 11일
처음 게시됨 (실제)
2026년 8월 17일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2026년 8월 17일
QC 기준을 충족하는 마지막 업데이트 제출
2026년 8월 11일
마지막으로 확인됨
2026년 8월 1일
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- JiangsuMC-20260806
- 2025JGYB272 (기타 보조금/기금 번호: Jiangsu Society of Higher Education)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
예
IPD 계획 설명
De-identified individual participant-level data supporting this study, together with a complete data dictionary, will be accessible to qualified external researchers upon reasonable written request after the primary manuscript is published.
Data release is conditional on institutional and regulatory privacy authorization.
All formal data access requests should be submitted to the corresponding author for evaluation and review.
No identifiable personal information will be included in shared datasets to protect student privacy.
IPD 공유 기간
De-identified individual participant data and supporting documents will be available to qualified researchers indefinitely after the publication of the primary study manuscript.
IPD 공유 액세스 기준
Data and supporting documents are available only to qualified academic researchers with legitimate educational research objectives.
All applicants shall submit a formal written research request to the corresponding author.
Data release is subject to institutional privacy and regulatory authorization.
Applicants must provide a clear research plan and agree to use the shared de-identified data solely for independent academic research, without attempting to re-identify participants or share datasets with third parties.
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
- ICF
- ANALYTIC_CODE
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
아니
미국 FDA 규제 기기 제품 연구
아니
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .